GMRE:NYE-Global Medical REIT Inc (USD)

COMMON STOCK | REIT - Healthcare Facilities |

Last Closing

USD 9.88

Change

+0.09 (+0.92)%

Market Cap

N/A

Volume

0.48M

Analyst Target

USD 14.79
Analyst Rating

N/A

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-09-24 )

Largest Industry Peers for REIT - Healthcare Facilities

Symbol Name Price(Change) Market Cap
WELL Welltower Inc

-0.99 (-0.77%)

USD 76.31B
VTR Ventas Inc

-0.25 (-0.39%)

USD 26.53B
DOC Healthpeak Properties Inc

+0.20 (+0.89%)

USD 15.39B
CTRE CareTrust REIT Inc.

-0.07 (-0.23%)

USD 4.68B
AHR American Healthcare REIT, Inc.

+0.17 (+0.65%)

USD 3.98B
NHI National Health Investors Inc

-0.89 (-1.05%)

USD 3.62B
LTC LTC Properties Inc

+0.12 (+0.33%)

USD 1.64B
UHT Universal Health Realty Income..

+0.65 (+1.42%)

USD 0.63B
CHCT Community Healthcare Trust Inc

-0.08 (-0.46%)

USD 0.47B
GMRE-PA Global Medical REIT Inc

+0.13 (+0.51%)

USD 0.41B

ETFs Containing GMRE

KBWY Invesco KBW Premium Yield.. 3.61 % 0.35 %

+0.07 (+0%)

USD 0.27B
SDEF 0.00 % 0.00 %

N/A

N/A

Market Performance

  Market Performance vs. Industry/Classification (REIT - Healthcare Facilities) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain -10.99% 14% F 14% F
Dividend Return 5.68% 79% B- 85% B
Total Return -5.32% 14% F 16% F
Trailing 12 Months  
Capital Gain 12.02% 21% F 42% F
Dividend Return 9.52% 93% A 90% A-
Total Return 21.54% 21% F 52% F
Trailing 5 Years  
Capital Gain -14.68% 46% F 27% F
Dividend Return 35.66% 100% F 89% A-
Total Return 20.98% 54% F 45% F
Average Annual (5 Year Horizon)  
Capital Gain -3.24% 43% F 22% F
Dividend Return 3.50% 43% F 42% F
Total Return 6.74% 79% B- 88% B+
Risk Return Profile  
Volatility (Standard Deviation) 25.06% 36% F 41% F
Risk Adjusted Return 13.98% 36% F 34% F
Market Capitalization N/A N/A N/A N/A N/A

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Superior total returns

The stock has outperformed its sector peers on average annual total returns basis in the past 5 years (for a hold period of at least 12 months) and is in the top quartile.

Superior Earnings Growth

This stock has shown top quartile earnings growth in the previous 5 years compared to its sector.

Superior Revenue Growth

This stock has shown top quartile revenue growth in the previous 5 years compared to its sector.

What to not like:
Poor risk adjusted returns

This company is delivering below median risk adjusted returns in its peers. Even if it is outperforming on returns , the returns are unpredictable. Proceed with caution.

Below median dividend returns

The company’s average income yield over the past 5 years has been low compared to its peers. However, it is not a problem if you are not looking for income.

High volatility

The total returns for this company are volatile and above median for its sector over the past 5 years. Make sure you have the risk tolerance for investing in such stock.